312 related articles for article (PubMed ID: 34320999)
1. Curcumin loaded sub-30 nm targeting therapeutic lipid nanoparticles for synergistically blocking nasopharyngeal cancer growth and metastasis.
Luo H; Lu L; Liu N; Li Q; Yang X; Zhang Z
J Nanobiotechnology; 2021 Jul; 19(1):224. PubMed ID: 34320999
[TBL] [Abstract][Full Text] [Related]
2. Nasopharyngeal cancer-specific therapy based on fusion peptide-functionalized lipid nanoparticles.
Luo H; Lu L; Yang F; Wang L; Yang X; Luo Q; Zhang Z
ACS Nano; 2014 May; 8(5):4334-47. PubMed ID: 24766601
[TBL] [Abstract][Full Text] [Related]
3. Curcumin and wikstroflavone B, a new biflavonoid isolated from Wikstroemia indica, synergistically suppress the proliferation and metastasis of nasopharyngeal carcinoma cells via blocking FAK/STAT3 signaling pathway.
Shao M; Lou D; Yang J; Lin M; Deng X; Fan Q
Phytomedicine; 2020 Dec; 79():153341. PubMed ID: 32992086
[TBL] [Abstract][Full Text] [Related]
4. Tuftsin-Bearing Liposomes Co-Encapsulated with Doxorubicin and Curcumin Efficiently Inhibit EAC Tumor Growth in Mice.
Murugesan K; Srinivasan P; Mahadeva R; Gupta CM; Haq W
Int J Nanomedicine; 2020; 15():10547-10559. PubMed ID: 33414637
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloprotein-triggered, cell penetrating peptide-modified star-shaped nanoparticles for tumor targeting and cancer therapy.
Guo F; Fu Q; Zhou K; Jin C; Wu W; Ji X; Yan Q; Yang Q; Wu D; Li A; Yang G
J Nanobiotechnology; 2020 Mar; 18(1):48. PubMed ID: 32183823
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
7. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
Jiang H; Geng D; Liu H; Li Z; Cao J
Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102
[TBL] [Abstract][Full Text] [Related]
8. Curcumin loaded polymeric micelles inhibit breast tumor growth and spontaneous pulmonary metastasis.
Liu L; Sun L; Wu Q; Guo W; Li L; Chen Y; Li Y; Gong C; Qian Z; Wei Y
Int J Pharm; 2013 Feb; 443(1-2):175-82. PubMed ID: 23287774
[TBL] [Abstract][Full Text] [Related]
9. Dual functional matrix metalloproteinase-responsive curcumin-loaded nanoparticles for tumor-targeted treatment.
Guo F; Fu Q; Jin C; Ji X; Yan Q; Yang Q; Wu D; Gao Y; Hong W; Li A; Yang G
Drug Deliv; 2019 Dec; 26(1):1027-1038. PubMed ID: 31691601
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.
Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O
Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729
[TBL] [Abstract][Full Text] [Related]
11. Radiosensitizing effect of curcumin-loaded lipid nanoparticles in breast cancer cells.
Minafra L; Porcino N; Bravatà V; Gaglio D; Bonanomi M; Amore E; Cammarata FP; Russo G; Militello C; Savoca G; Baglio M; Abbate B; Iacoviello G; Evangelista G; Gilardi MC; Bondì ML; Forte GI
Sci Rep; 2019 Jul; 9(1):11134. PubMed ID: 31366901
[TBL] [Abstract][Full Text] [Related]
12. Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer.
Zhao X; Chen Q; Liu W; Li Y; Tang H; Liu X; Yang X
Int J Nanomedicine; 2015; 10():257-70. PubMed ID: 25565818
[TBL] [Abstract][Full Text] [Related]
13. Scavenger receptor B1 is a potential biomarker of human nasopharyngeal carcinoma and its growth is inhibited by HDL-mimetic nanoparticles.
Zheng Y; Liu Y; Jin H; Pan S; Qian Y; Huang C; Zeng Y; Luo Q; Zeng M; Zhang Z
Theranostics; 2013; 3(7):477-86. PubMed ID: 23843895
[TBL] [Abstract][Full Text] [Related]
14. Enhanced photocytotoxicity of curcumin delivered by solid lipid nanoparticles.
Jiang S; Zhu R; He X; Wang J; Wang M; Qian Y; Wang S
Int J Nanomedicine; 2017; 12():167-178. PubMed ID: 28053531
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic effect of curcumin on NPC/CNE2 cells.
Koon H; Leung AW; Yue KK; Mak NK
J Environ Pathol Toxicol Oncol; 2006; 25(1-2):205-15. PubMed ID: 16566718
[TBL] [Abstract][Full Text] [Related]
16. Skin-penetrating polymeric nanoparticles incorporated in silk fibroin hydrogel for topical delivery of curcumin to improve its therapeutic effect on psoriasis mouse model.
Mao KL; Fan ZL; Yuan JD; Chen PP; Yang JJ; Xu J; ZhuGe DL; Jin BH; Zhu QY; Shen BX; Sohawon Y; Zhao YZ; Xu HL
Colloids Surf B Biointerfaces; 2017 Dec; 160():704-714. PubMed ID: 29035818
[TBL] [Abstract][Full Text] [Related]
17. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
[TBL] [Abstract][Full Text] [Related]
18. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo.
Chen Y; Pan L; Jiang M; Li D; Jin L
Drug Deliv; 2016 May; 23(4):1383-92. PubMed ID: 26066035
[TBL] [Abstract][Full Text] [Related]
19. Polyethylene Glycol-Coated Graphene Oxide Loaded with Erlotinib as an Effective Therapeutic Agent for Treating Nasopharyngeal Cancer Cells.
Lan MY; Hsu YB; Lan MC; Chen JP; Lu YJ
Int J Nanomedicine; 2020; 15():7569-7582. PubMed ID: 33116488
[TBL] [Abstract][Full Text] [Related]
20. Anticancer and Antibacterial Properties of Curcumin-Loaded Mannosylated Solid Lipid Nanoparticles for the Treatment of Lung Diseases.
Chae J; Choi Y; Hong J; Kim N; Kim J; Lee HY; Choi J
ACS Appl Bio Mater; 2024 Apr; 7(4):2175-2185. PubMed ID: 38478917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]